Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05786> ?p ?o ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB05786 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05786 label "MGI-114 [drugbank:DB05786]" assertion.
- drugbank:DB05786 seeAlso DB05786 assertion.
- drugbank:DB05786 identifier "drugbank:DB05786" assertion.
- drugbank:DB05786 description "A novel anti-cancer compound synthesized by scientists at the University of California, San Diego more than a decade ago from toxins of the poisonous jack-o-lantern mushroom, has been granted “fast track” status by the U.S. Food and Drug Administration (FDA) after demonstrating promise against one of the most deadly cancers. MGI-114 (Irofulven) is currently being developed by MGI PHARMA, Inc., an emerging oncology-focused pharmaceutical company based in Minneapolis. Phase III clinical trials involving the drug have been underway since early 2001 at sites in the U.S. and Europe." assertion.
- drugbank:DB05786 title "MGI-114" assertion.
- drugbank:DB05786 bio2rdf_vocabulary:identifier "DB05786" assertion.
- drugbank:DB05786 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05786 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05786" assertion.
- drugbank:DB05786 bio2rdf_vocabulary:x-identifiers.org DB05786 assertion.
- drugbank:DB05786 drugbank_vocabulary:drugbank-id "DB05786" assertion.
- drugbank:DB05786 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05786 drugbank_vocabulary:x-chemspider chemspider:130640 assertion.
- drugbank:DB05786 drugbank_vocabulary:x-pubchemcompound pubchem.compound:148189 assertion.
- drugbank:DB05786 drugbank_vocabulary:x-wikipedia wikipedia:Irofulven assertion.
- drugbank:DB05786 drugbank_vocabulary:x-bindingdb bindingdb:50092217 assertion.